StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.99−0.02 (-1.00%)

Close on Nov 18, 2026Market cap $14.66MP/E –Yield –

GeoVax Labs revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

GeoVax Labs's revenue for the twelve months ending Jun 30, 2026 was $0, down 100.0% year over year. For fiscal 2025 it was $2.49M, down 37.1% from the year before. The highest annual figure on record is $3.95M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.49M-37.1%
FY2024Dec 31, 2024$3.95M–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$81.53K-78.9%
FY2021Dec 31, 2021$385.50K-78.9%
FY2020Dec 31, 2020$1.82M+55.1%
FY2019Dec 31, 2019$1.18M+22.1%
FY2018Dec 31, 2018$963.20K-10.4%
FY2017Dec 31, 2017$1.08M+29.7%
FY2016Dec 31, 2016$828.92K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$0-100.0%
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$852.28K+183.5%
Q1 FY2025Mar 31, 2025$1.64M–
Q4 FY2024Dec 31, 2024$864.42K–
Q3 FY2024Sep 30, 2024$2.79M–
Q2 FY2024Jun 30, 2024$300.68K–
Q1 FY2024Mar 31, 2024$0–
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$0-100.0%
Q2 FY2022Jun 30, 2022$0-100.0%
Q1 FY2022Mar 31, 2022$81.53K-26.2%
Q4 FY2021Dec 31, 2021$164.96K-34.4%
Q3 FY2021Sep 30, 2021$30.41K-92.7%
Q2 FY2021Jun 30, 2021$79.71K-81.9%
Q1 FY2021Mar 31, 2021$110.42K-84.6%
Q4 FY2020Dec 31, 2020$251.62K-6.3%
Q3 FY2020Sep 30, 2020$415.46K+24.7%
Q2 FY2020Jun 30, 2020$440.60K+109.9%
Q1 FY2020Mar 31, 2020$715.98K+96.6%
Q4 FY2019Dec 31, 2019$268.51K-10.3%
Q3 FY2019Sep 30, 2019$333.21K-4.6%
Q2 FY2019Jun 30, 2019$209.94K+125.1%
Q1 FY2019Mar 31, 2019$364.23K+64.6%
Q4 FY2018Dec 31, 2018$299.30K+66.8%
Q3 FY2018Sep 30, 2018$349.34K+40.9%
Q2 FY2018Jun 30, 2018$93.27K-73.5%
Q1 FY2018Mar 31, 2018$221.30K-25.2%
Q4 FY2017Dec 31, 2017$179.40K–
Q3 FY2017Sep 30, 2017$247.99K–
Q2 FY2017Jun 30, 2017$352.14K–
Q1 FY2017Mar 31, 2017$295.74K–

More GeoVax Labs figures

See a number that looks wrong?